Neuregulin4 Acts on Hypothalamic ErBb4 to Excite Oxytocin Neurons and Preserve Metabolic Homeostasis.

Neuregulin4 Acts on Hypothalamic ErBb4 to Excite Oxytocin Neurons and Preserve Metabolic Homeostasis.
复制标题

Neuregulin4作用于下丘脑ErBb4以兴奋催产素神经元并保持代谢稳态。

DOI:
10.1002/advs.202204824
复制
发表时间:
2023-06
期刊:
影响因子:
15.1
通讯作者:
Hu, Cheng
Hu, Cheng
中科院分区:
材料科学1区
文献类型:
--
作者:
Zhang, Yi;Zhu, Yangyang;Wang, Jinghui;Jin, Li;Guo, Mingwei;Chen, Liwei;Zhang, Lina;Li, Yangyang;Wan, Baocheng;Zhang, Rong;Jia, Weiping;Hu, Cheng

文献摘要

参考文献

相似文献

Neuregulin 4 (Nrg4) is an adipose tissue‐enriched secreted factor that modulates glucose and lipid metabolism. Nrg4 is closely associated with obesity and preserves diet‐induced metabolic disorders. However, the specific mechanisms via which Nrg4 regulates metabolic homeostasis remain incompletely understood. Here, this work finds that the Nrg4 receptor, ErbB4, is highly expressed in the hypothalamus, and the phosphorylation of hypothalamic ErbB4 is reduced in diet‐induced obesity (DIO) mice. Peripheral Nrg4 can act on ErbB4 via blood circulation and excite neurons in the paraventricular nucleus of hypothalamus (PVN). Central administration of recombinant Nrg4 protein (rNrg4) reduces obesity and related metabolic disorders by influencing energy expenditure and intake. Overexpression of ErbB4 in the PVN protects against obesity, whereas its knock down in oxytocin (Oxt) neuron accelerates obesity. Furthermore, Nrg4‐ErbB4 signaling excites Oxt release, and ablation of Oxt neuron considerably attenuates the effect of Nrg4 on energy balance. These data suggest that the hypothalamus is a key target of Nrg4, which partially explains the multifaceted roles of Nrg4 in metabolism. Nrg4 secreted by adipose tissues can act on the ErbB4 receptor of oxytocin neurons in the hypothalamus and promote release of oxytocin peptide. Central administration of rNrg4 ameliorates dietary obesity by reducing appetite and increasing energy expenditure. This work highlights central Nrg4‐ErbB4 signaling as a potential therapeutic strategy for the treatment of obesity and related diseases.
DOI: 10.4161/adip.29853
发表时间: 2015-01
期刊: Adipocyte
影响因子: 3.3
作者:
Christian M
通讯作者: Christian M
DOI: 10.1523/jneurosci.2021-14.2014
发表时间: 2014-10-01
影响因子: 5.3
作者:
Bean, Jonathan C.;Lin, Thiri W.;Mei, Lin
通讯作者: Mei, Lin
DOI: 10.1161/circulationaha.111.087213
发表时间: 2012-07-03
期刊: Circulation
影响因子: 37.8
作者:
Hill JO;Wyatt HR;Peters JC
通讯作者: Peters JC
DOI: 10.1038/nn.2467
发表时间: 2010-01
影响因子: 25
作者:
Madisen L;Zwingman TA;Sunkin SM;Oh SW;Zariwala HA;Gu H;Ng LL;Palmiter RD;Hawrylycz MJ;Jones AR;Lein ES;Zeng H
通讯作者: Zeng H
DOI: 10.1016/j.molmet.2017.03.016
发表时间: 2017-08
影响因子: 8.1
作者:
Chen Z;Wang GX;Ma SL;Jung DY;Ha H;Altamimi T;Zhao XY;Guo L;Zhang P;Hu CR;Cheng JX;Lopaschuk GD;Kim JK;Lin JD
通讯作者: Lin JD